From: A longitudinal evaluation of the impact of a polylactic acid injection therapy on health related quality of life amongst HIV patients treated with anti-retroviral agents under real conditions of use
Inclusion visit
Monitoring visit 2 months
Monitoring visit 12–18 months
N=177
N=90
Grade
0 No visible FL
1.1%
34.5%
21.3%
1
19.2%
42.9%
37.1%
2
48.0%
16.9%
30.3%
3
27.1%
5.6%
11.2%
4
4.5%
0.0%